
ConcertAI
Founded Year
2017Stage
Series C | AliveTotal Raised
$320MValuation
$0000Last Raised
$150M | 3 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-67 points in the past 30 days
About ConcertAI
ConcertAI specializes in clinical artificial intelligence and real-world data products within the healthcare sector. The company offers a suite of AI-driven solutions and services designed to optimize clinical trials, provide predictive patient insights, and support commercial healthcare solutions. ConcertAI primarily serves the oncology research and clinical development sectors. It was founded in 2017 and is based in Cambridge, Massachusetts.
Loading...
ESPs containing ConcertAI
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
ConcertAI named as Outperformer among 15 other companies, including IQVIA, Tempus, and Datavant.
Loading...
Research containing ConcertAI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ConcertAI in 5 CB Insights research briefs, most recently on Aug 21, 2024.

Aug 21, 2024
The clinical trials tech market map
Expert Collections containing ConcertAI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ConcertAI is included in 8 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
AI 100
100 items
The winners of the 4th annual CB Insights AI 100.
Conference Exhibitors
5,302 items
Digital Health 50
150 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,305 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
ConcertAI Patents
ConcertAI has filed 1 patent.
The 3 most popular patent topics include:
- artificial neural networks
- classification algorithms
- machine learning

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
10/29/2021 | Machine learning, Artificial neural networks, Classification algorithms, Machine learning algorithms, Statistical classification | Application |
Application Date | 10/29/2021 |
---|---|
Grant Date | |
Title | |
Related Topics | Machine learning, Artificial neural networks, Classification algorithms, Machine learning algorithms, Statistical classification |
Status | Application |
Latest ConcertAI News
Mar 26, 2025
Treble Grows Tech Practice, Onboards Multiple Late-Stage Clients LogicMonitor joins as a cornerstone account, selecting Treble as its U.S. PR agency of record Growth strategy bolstered with late-stage clients, including SymphonyAI, ConcertAI, ZEDEDA, Azul, and Zilliant Recent award wins include Top PR Agency (Ragan Communications and PR Daily), Agency of the Year (Business Intelligence), and Agency Elite in Technology (PR News) Treble, the premier earned media B2B technology public relations agency, today announced a significant expansion of its Enterprise Technology Practice Group, marked by new enterprise client wins and continued growth with later-stage companies. The expansion is anchored by Treble’s recent selection as the U.S. public relations agency of record for LogicMonitor, a leading vendor for AI-powered SaaS-based hybrid observability. “Winning the LogicMonitor RFP is a testament to the collective strength of our team and Treble’s deep-rooted credibility at the intersection of enterprise technology and AI,” said Will Kruisbrink, vice president at Treble. “With multiple pre-IPO and publicly traded companies on our client roster, we plan to continue to scale and win with late-stage companies while forming strategic partnerships with innovative early-stage startups.” Since its inception, Treble has steadily evolved to work with later-stage companies, building on its foundation with early-stage venture-backed startups. In addition to LogicMonitor, the agency’s enterprise technology portfolio includes SymphonyAI, ConcertAI, ZEDEDA, Azul, and Zilliant. “Treble has reached a defining moment in our evolution, fueled by our growing momentum with later-stage companies and the expansion of our Enterprise Technology Practice Group,” said Matt Grant, Senior Vice President and head of the Enterprise Technology Practice Group at Treble. “We are making bold investments in top-tier talent to reinforce Treble as the premier communications partner for enterprise technology leaders seeking to dominate their markets.” This growth builds on Treble’s validation in the market through its extensive relations across the venture capital ecosystem. While the agency’s foundation is in Texas, it has since expanded its headcount and client roster across the United States and back into Silicon Valley, and the agency continues to build up its international partner network. “Following a highly competitive RFP process, we’re excited to partner with Treble as our PR agency in the U.S. market,” said Brooke Cunningham, Chief Marketing Officer at LogicMonitor. “As we pursue ambitious growth targets for 2025 and beyond, Treble’s earned media expertise will be instrumental in amplifying our brand, shaping industry narratives, and driving market influence.” Artificial Intelligence & Hardtech Practice Groups Also Gain Market Traction Treble has been a strategic partner in helping 27 companies to date achieve successful exits through either acquisition or public offering, with three IPOs and over 100 funding launches to date. With the agency’s expertise in supporting VC-backed, emerging-growth tech companies, Treble continues strengthening its core business while expanding its partnerships with venture capital firms. The agency continues to build out its talent in core cities, including Austin, San Francisco, and San Diego, to support the needs of enterprise technology companies. Treble’s expertise spans various technology sectors within the enterprise space, including artificial intelligence, DevOps, cybersecurity, SaaS, and edge computing, as well as disruptive technologies across traditional industries such as finance, healthcare, and climate tech. The past year saw the launch of two specialized divisions: an Artificial Intelligence Practice Group in April and a Hardtech Practice Group in October. Will Kruisbrink, Vice President of Treble’s San Francisco office, leads both practice groups. This brings the total to four dedicated practice groups, including Cybersecurity and Enterprise Technology. “Our expansion into the enterprise market is a testament to our decade-long commitment to building a team with a deep focus on earned media from day one,” said Ethan Parker, founder and CEO of Treble. “With the right expertise and talent firmly in place, Treble has emerged as a bold and exceptional choice for enterprise technology companies seeking a steady cadence of earned media results to drive growth.” Strategic Services at Every Growth Stage Treble works closely with investor relations teams and investor-centric publications to guide companies up to and through successful IPOs while maintaining our commitment to driving meaningful results for growth-stage clients across all sectors. Building on a long track record of success across the spectrum of tech companies, Treble offers customized programs for businesses at every stage. These include its Funding Accelerator, a 30-day PR sprint that provides startups with brand visibility while closing funding rounds, and Elevate, a 10-week PR program that builds on the momentum after an initial funding announcement with additional media coverage. To learn more, contact us at newbiz@treblepr.com.
ConcertAI Frequently Asked Questions (FAQ)
When was ConcertAI founded?
ConcertAI was founded in 2017.
Where is ConcertAI's headquarters?
ConcertAI's headquarters is located at 1120 Massachusetts Avenue, Cambridge.
What is ConcertAI's latest funding round?
ConcertAI's latest funding round is Series C.
How much did ConcertAI raise?
ConcertAI raised a total of $320M.
Who are the investors of ConcertAI?
Investors of ConcertAI include Sixth Street Partners, AllianceBernstein, Maverick Ventures Israel, Declaration Partners, SymphonyAI and 3 more.
Who are ConcertAI's competitors?
Competitors of ConcertAI include Aetion, Mendel AI, Zephyr AI, Holmusk, nference and 7 more.
Loading...
Compare ConcertAI to Competitors

Owkin is an AI biotechnology company that employs artificial intelligence to improve drug discovery and development in the biopharmaceutical sector. The company specializes in AI-based identification of new treatments, clinical trial optimization, and diagnostic tool creation, while ensuring patient privacy through federated learning techniques. Owkin serves the biopharma and academic research communities. It was founded in 2016 and is based in New York, New York.

Aetion provides real-world evidence solutions within the healthcare sector. The company offers software and services that analyze real-world data to provide insights on the safety, effectiveness, and value of medical treatments and technologies. Its clientele includes biopharma companies and government agencies to inform health care decisions and guide product development. It was founded in 2012 and is based in New York, New York.

Promptly Health offers real-world evidence solutions within the healthcare sector. The company provides services that include generating knowledge from clinical, socio-economic, and claims data, as well as collecting longitudinal patient-reported data and digital biomarkers. Promptly Health serves life sciences, healthcare providers, and healthcare payers. It was founded in 2017 and is based in Porto, Portugal.

Verantos specializes in real-world evidence within the life sciences sector. The company has a platform that combines various real-world data sources to produce research-grade evidence, using clinical narrative data and artificial intelligence technology. This evidence is used for market access, medical affairs, and regulatory initiatives across therapeutic areas. It was founded in 2015 and is based in Menlo Park, California.

nference is a healthcare technology company specializing in clinical artificial intelligence (AI) and evidence. The company offers a platform that uses healthcare data to manage clinical data, support research, and work with patient outcomes through artificial intelligence. nference primarily serves the healthcare sector, providing solutions for clinical researchers, data scientists, and healthcare systems. It was founded in 2013 and is based in Cambridge, Massachusetts.

Holmusk is a data analytics and health technology company that focuses on behavioral health within the healthcare sector. The company offers a real-world evidence platform that combines a behavioral health database with analytics and digital solutions to support research and care. Holmusk's services include HolCare EHR+, an electronic health records platform with measurement-based care, and NeuroBlu Research, a data analytics solution for building patient cohorts and exploring datasets. It was founded in 2015 and is based in New York, New York.
Loading...